Logo Logo
Group by: Item Type | Date
Jump to: 2018 | 2016
Number of items: 3.

2018

Stelzer, D.; Weber, A.; Ihle, F.; Matthes, S.; Ceelen, F.; Zimmermann, G.; Kneidinger, N.; Schramm, R.; Winter, H.; Zoller, M.; Vogeser, M.; Behr, J. and Neurohr, C. (2018): Posaconazole liquid vs tablet formulation in lung transplant recipients. In: Mycoses, Vol. 61, No. 3: pp. 186-194

2016

Stelzer, D.; Ihle, F.; Weber, A.; Kneidinger, N.; Ceelen, E.; Zimmermann, G.; Schramm, R.; Winter, H.; Frey, L.; Andraschko, M.; Vogeser, M.; Behr, J. and Neurohr, C. (2016): Posaconazol Tablets in Lung Transplant Recipients: Plasma Trough Levels and Influencing Factors. In: Journal of Heart and Lung Transplantation, Vol. 35, No. 4: S310-S310

Stelzer, D.; Ihle, F.; Weber, A.; Kneidinger, N.; Zimmermann, G.; Ceelen, F.; Schramm, R.; Winter, H.; Frey, L.; Andraschko, M.; Vogeser, M.; Behr, J. and Neurohr, C. (2016): Impact Of Posaconazol Liquid Vs. Tablet Formulation On Plasma Trough Levels In Lung Transplant Recipients. In: American Journal of Respiratory and Critical Care Medicine, Vol. 193

This list was generated on Sun Apr 14 06:42:28 2024 CEST.